Obesity Is a Chronic, Hormone-Driven Disease
7 Still, Le, who is also a general surgery registrar at Royal Melbourne Hospital, says, I think it is too early to say this is a robust, durable, and generalizable effect given the high heterogeneity of underlying studies. He notes a need for more rigorous randomized controlled trials with longer follow-up times to better characterize the impact of these medications on weight and OSA together, as well as gain a better understanding of effect size, optimal doses, side effects, interactions with other medications, and impacts on other comorbidities
J Neuroimmune Pharmacol 20 , 43 (2025)
Stigma Reduction One of the most distinctive traits these companies delivering very different medications share is their reframing of stigma and behavioral goals
1,2,3 It has the potential to help your body feel more balanced and comfortable while using GLP-1 medications.* 2